Altimmune (ALT) Non-cash Items (2016 - 2026)

Altimmune (ALT) has 11 years of Non-cash Items data on file, last reported at $513000.0 in Q1 2026.

• Non-cash Items for Q1 2026 came in at $513000.0, down 79.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $513000.0 (down 79.5% YoY), and the FY2025 annual result was $4.8 million, down 17.3% from the prior year.
• Non-cash Items fell to $513000.0 in Q1 2026 per ALT's latest filing, from $877000.0 in the prior quarter.
• Over five years, Non-cash Items peaked at $25.7 million in Q4 2022 and troughed at $3642.0 in Q2 2022.
• A 5-year average of $5.2 million and a median of $2.5 million in 2025 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2024: Non-cash Items sank 99.98% in 2022, then soared 50700.12% in 2024.
• A 5-year view of Non-cash Items shows it stood at $25.7 million in 2022, then slumped by 34.23% to $16.9 million in 2023, then plunged by 65.49% to $5.8 million in 2024, then slumped by 84.98% to $877000.0 in 2025, then tumbled by 41.51% to $513000.0 in 2026.
• Business Quant data shows ALT's Non-cash Items at $513000.0 in Q1 2026, $877000.0 in Q4 2025, and $4.5 million in Q3 2025.